文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
A. Psyrri
发表
KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
R. Greil, K. Harrington, A. Psyrri, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.